Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ARWR
CAI
Add up to 3 more stocks
ARWR
Arrowhead Pharmaceuticals, Inc.
-1.88%
$61.18-1.17Delayed quote: Oct 6, 2026, 10:55 AM EDT
Market Cap
$8.62B
52W Range
$34.61 - $95.49
CAI
Caris Life Sciences, Inc.
-4.44%
$29.04-1.35Delayed quote: Oct 6, 2026, 10:55 AM EDT
Market Cap
$8.21B
52W Range
$14.19 - $33.66
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 81.14 |
| Forward P/E | N/A | 250.29 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 18.51 | 13.87 |
| P/S Ratio | 12.87 | 8.30 |
| P/FCF Ratio | N/A | 56.04 |
| EV/EBITDA | N/A | 45.80 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 69.7% |
| Operating Margin | 11.9% | 5.6% |
| Net Margin | -47.8% | 10.6% |
| ROE | -68.7% | 17.8% |
| ROA | -15.2% | 8.6% |
| ROIC | -12.1% | 14.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.90 | 5.53 |
| Quick Ratio | 5.90 | 4.88 |
| Debt/Equity | 1.86 | 0.76 |
| Interest Coverage | 1.10 | 0.79 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.